Alfred Sze-Lok Cheng
5PUBLICATIONS
10CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (5)
Sort by Publication Date:
|Nov 01, 2024
Pharmacological activation of STAT1-GSDME pyroptotic circuitry reinforces epigenetic immunotherapy for hepatocellular carcinoma.Yalin Tu, Haoran Wu, Chengpeng Zhong
|Apr 05, 2023
Targeting PPAR-gamma counteracts tumour adaptation to immune-checkpoint blockade in hepatocellular carcinoma.Zhewen Xiong, Stephen Lam Chan, Jingying Zhou
|Jan 02, 2023
Meltdown of the cold tumour microenvironment: a new 'translational' approach to augment immunotherapy efficacy.Alfred Sze-Lok Cheng
|Nov 30, 2022
Isoformic PD-1-mediated immunosuppression underlies resistance to PD-1 blockade in hepatocellular carcinoma patients.Zhiwu Tan, Mei Sum Chiu, Xinxiang Yang
|May 12, 2019
Targeting monocyte-intrinsic enhancer reprogramming improves immunotherapy efficacy in hepatocellular carcinoma.Man Liu, Jingying Zhou, Xiaoyu Liu
Pageof 1
Frequent Collaborators
2 joint publications
Joseph Jao-Yiu Sung
1 joint publications
Minhu Chen
1 joint publications
Yuewen Wang
1 joint publications
Li Liu
1 joint publications
Kwan Man
1 joint publications
Zhiwei Chen
1 joint publications
Jianquan Cao
1 joint publications
Jianxin Liang
1 joint publications
Stephanie Ma
1 joint publications
Jingying Zhou
